Exploring patient participation in reducing health-care-related safety risks

More documents

Recommendations

Info

Exploring patient participation in reducing health-care-related safety risks 162 ANNEX 5. DOCTOR QUESTIONNAIRE ABOUT MEDICATION SAFETY PATIENT SAFETY RIGHTS AND MEDICATION SAFETY WHO Patient Safety Rights Project The questionnaire intends to describe whether safe medication practices are being used in everyday practice while prescribing the new medication and continuing patient medicine treatment. Please mark the appropriate choice for each of the questions below. This survey is anonymous and information obtained will be used solely for the purpose of this study. Please just indicate your sex and age at the final page of questionnaire. Thank you for your input and cooperation. 1 Physician No specialty 1st degree specialist 2nd degree specialist (highest) 2. Do you expect patients to provide detailed information about recently taken medication at the first visit? YES NO 3. Please describe which of the factors below are most important regarding drug prescribing: A Patient age B Risk of interaction C Risk of adverse events D Comorbidities that might affect medicines outcomes 4. Do you ask your patients about the OTC drugs and/or dietary supplements they might be taking? YES NO 5. Do you always ask your patients about the names of medications they recently took? YES NO 6. Have you treated a patient/patients who have appointments due to adverse drug reaction to an OTC drug? YES NO 7. Have you treated a patient/patients who visit due to adverse drug reaction to a dietary supplement or herbal medicines? YES NO 8. Do you ask patients about possible adverse drug reactions before prescribing new medication? NEVER ALWAYS SOMETIMES 9. Do you reflect upon the possible undesired interaction with medicines already taken before prescribing a new drug? YES NO 10. Please define the number of simultaneously taken medicines for which the statistical risk of drug interactions results in certainty. A 1–3 medications B 3–5 medications C 5–7 medications D More than 8 medications 11. Do you expect the patient to have a list of their medication names and doses? YES NO 12. In case of adverse drug reaction, do you report this to the designated authorities? 13. SEX 14. AGE NEVER ALWAYS SOMETIMES FEMALE MALE Years
ANNEX 6. WhO pATIENT SAFETY pROGRAMME The WHO Patient Safety Programme includes a number of activities, programmes and campaigns that aim to coordinate, disseminate and accelerate improvements in patient safety worldwide. Launched in 2004 in response to a 2002 World Health Assembly resolution urging WHO and Member States to pay the closest possible attention to the problem of patient safety, its establishment underlined the importance of patient safety as a global health care issue. Its main areas of work – which in Member States that adopt them should have the potential to influence the patients’ rights agenda – have included the action areas set out here. Global Patient Safety Challenges Global Patient Safety Challenges aim to identify a topic that covers a major and significant aspect of risk to patients receiving health care and which is relevant to every WHO Member State. Two such challenges have been launched to date by WHO, as described below. The third challenge on Medication Safety will be initiated in 2013. 1 . “Clean Care is Safer Care” HAI was chosen as the First Global Patient Safety Challenge, focusing on the theme “Clean Care is Safer Care” (1). As part of this challenge, WHO guidelines on hand hygiene in health care were developed, along with a set of complementary implementation tools. 2 . “Safe Surgery Saves Lives” Safer surgery was chosen as the Second Global Patient Safety Challenge, with the theme “Safe Surgery Saves Lives” (2). The focus of the campaign is the WHO surgical safety checklist. The checklist identifies three phases of an operation, each corresponding to a specific period in the normal flow of work: before the induction of anaesthesia (“sign in”); before the incision of the skin (“time out”); and before the patient leaves the operating room (“sign out”). In each phase, a checklist coordinator must confirm that the surgical team has completed the listed tasks before it proceeds with the operation. 3 . Medication safety The safety of medicines is not a new area of activity for WHO, but the WHO Patient Safety Programme will be building on positive work done in medicines regulation and management of counterfeit medicines to develop the Third Global Patient Safety Challenge in “Medication Safety”. This area will develop advocacy messages as well as technical tools for improving medication safety across the spectrum of health care settings. “Patients for Patient Safety” In the area of patient and consumer involvement, the initiative “Patients for Patient Safety” (3) involves building a patient-led global network of patients and patient organizations to champion patient safety. WHO Patient Safety Programme 163
Page 1 and 2:
Exploring patient participation in
Page 3 and 4:
ABSTRACT Patients’ rights have be
Page 5 and 6:
iv Patient information: the link be
Page 7 and 8:
vi LIST OF TABLES, FIGURES AND BOXE
Page 9 and 10:
ACKNOWLEDGEMENTS The editors would
Page 11 and 12:
LIST OF ABBREVIATIONS ABHR alcohol-
Page 13 and 14:
FOREWORD Health is a social value a
Page 15 and 16:
ChApTER 1. pATIENTS’ RIGhTS AND p
Page 17 and 18:
Box 1 .1 . contd Reporting and Lear
Page 19 and 20:
The causal mechanisms through which
Page 21 and 22:
» be involved in routine monitorin
Page 23 and 24:
elationships within the complex env
Page 25 and 26:
ChApTER 2. pATIENTS’ RIGhTS AND p
Page 27 and 28:
CoE Recommendation 2006/7 of the Co
Page 29 and 30:
The 2005 United States act on patie
Page 31 and 32:
The right to participate in policy-
Page 33 and 34:
The right to participate in quality
Page 35 and 36:
» engaging with patient representa
Page 37 and 38:
hampered by the written and spoken
Page 39 and 40:
prevents misunderstandings and shap
Page 41 and 42:
Health care providers should nevert
Page 43 and 44:
Recommendation 7 - Encourage the av
Page 45 and 46:
20. Constitution of the World Healt
Page 47 and 48:
ChApTER 3. pATIENT pARTICIpATION IN
Page 49 and 50:
awareness of the sociomedical burde
Page 51 and 52:
Patient participation in hand hygie
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Blood transfusion safety in France:
Page 63 and 64:
Page 65 and 66:
Box 4 .1 . Definitions of adverse e
Page 67 and 68:
Fig . 4 .4 . Distribution of advers
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
The heterogeneity of situations and
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Fig . 4 .12 . Patients’ response
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Patient safety, rights and medicati
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Fig . 5 .3 . Frequency with which d
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
ChApTER 6. pATIENT pARTICIpATION IN
Page 109 and 110:
Patient participation in elective s
Page 111 and 112:
e desirable to have a special statu
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
inspections of surgical services to
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126: Patient participation in elective s
Page 133 and 134: » being involved in monitoring and
Page 135 and 136: Other studies on patient attitudes
Page 137 and 138: Information about patients’ exper
Page 139 and 140: available evidence suggests that in
Page 141 and 142: Adverse events Respondents from the
Page 143 and 144: Feeling safe Five per cent of hospi
Page 145 and 146: probability proportional to populat
Page 147 and 148: care professionals’ and patients
Page 149 and 150: group recommends that patient invol
Page 151 and 152: 13. Hibbard JH et al. Can patients
Page 153 and 154: 52. Triemstra M et al. Measuring cl
Page 155 and 156: 2009 (http://www.bradfordresearch.n
Page 157 and 158: of a small-scale patient survey add
Page 159 and 160: Box 8 .2 . Curricula and CME Chapte
Page 161 and 162: is provided through interaction of
Page 163 and 164: Box 8 .4 . Patient education Chapte
Page 165 and 166: ANNEX 1. QUOTATIONS FROM INTERNATIO
Page 167 and 168: (2) When designing adverse event re
Page 169 and 170: 17) If yes, do you think this was m
Page 171 and 172: Box A3 .1 . Reporting procedure Pat
Page 173 and 174: Box A3 .2 . contd Haemosiderosis Ha
Page 175: ANNEX 4. pATIENT QUESTIONNAIRE ABOU
Page 179 and 180: especially those in intensive care.
Page 181 and 182: ANNEX 7. hANDOVER pROjECT Paul Bara
Page 183 and 184: (a) Provide new insight into the ro
Page 185 and 186: Johnson J, Barach P. Handovers of p
Page 187 and 188: Enhancing the patients’ role in p
Page 189 and 190: Enhancing the patients’ role in p
show all

Exploring patient participation in reducing health-care-related safety risks

Create successful ePaper yourself

Delete template?

Save as template?